Background: The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) is a world leader in the provision of external quality assurance (EQA) for pathology laboratories. The development and delivery of new programmes are designed to meet the evolving needs of our participants and pathology practice. A cytopathology technical programme was established in 2018 to provide proficiency testing in routine cytopreparatory techniques. The cytopathology technical pilot focused on standard operating procedures and laboratory performance during rapid on-site evaluation (ROSE). The exercise aimed to assess the diagnostic adequacy and provide technical recommendations on each of the whole slide images from four fine-needle aspiration biopsy (FNAB) samples of the thyroid in a setting of ROSE. Methods: Four whole slide imaging cases, each comprising one Diff-QuikTM stained preparation of an FNAB of the thyroid, were provided to all laboratories currently enrolled in the RCPAQAP Cytopathology diagnostic programmes. Each scanned image represented one slide from the first pass collected by a radiologist under ultrasound guidance. Participating laboratories were encouraged to distribute the exercise to individual staff members who attend ROSE procedures. A laboratory practice questionnaire was also conducted. Results: There were a total of 186 submissions received for the assessment across the four virtual cases provided. Although the assessment of on-site adequacy by participants showed high concordance across some of the cases, there was variation in the initial diagnostic evaluation and technical recommendation. Conclusions: ROSE has been adopted as a standard procedure in many laboratories worldwide. A peer comparison of participating laboratories in an EQA exercise has highlighted ROSE as susceptible to variation across standard operating procedures, the provision of diagnostic adequacy, diagnostic feedback to the attending clinician, and technical recommendation.

1.
Cummings
MC
,
Greaves
J
,
Shukor
RA
,
Perkins
G
,
Ross
J
.
Technical proficiency in cytopathology: assessment through external quality assurance
.
Cytopathology
.
2017 Apr
;
28
(
2
):
149
56
.
2.
Ali
S
,
Cibas
E
.
The Bethesda system for reporting thyroid cytopathology
.
Springer
;
2010
.
3.
The Royal College of Pathologists of Australasia (RCPA)
.
Thyroid cytology structured reporting protocol
. 1st ed.
2014
.
4.
Sarkis
LM
,
Norlén
O
,
Aniss
A
,
Watson
N
,
Delbridge
L
,
Sidhu
S
,
The Australian experience with the Bethesda classification system for thyroid fine needle aspiration biopsies
.
Pathology
.
2014
;
46
(
7
):
592
5
.
5.
Field
A
,
Zarka
M
.
Practical cytopathology: a diagnostic approach to fine needle aspiration biopsy
.
Elsevier
;
2017
. p.
p329
30
.
6.
Orell
S
,
Sterrett
G
,
Whitaker
D
.
Fine needle aspiration
. 4th ed.
Elsevier
;
2005
. p.
p2
4
.
7.
de Koster
EJ
,
Kist
JW
,
Vriens
MR
,
Borel Rinkes
IH
,
Valk
GD
,
de Keizer
B
.
Thyroid ultrasound guided fine needle aspiration: the positive influence of onsite adequacy assessment and number of needle passes on diagnostic cytology rate
.
Acta Cytol
.
2016
;
60
:
39
45
.
8.
Zadowski
M
.
“That which we call a rose”: a critical analysis of rapid onsite evaluation
.
Cancer Cytopath
.
2016
;
12
:
857
61
.
9.
The Papanicolaou Society of Cytopathology Task Force on Standards for Practice
.
Guidelines of the papanicolaou society of cytopathology for fine-needle aspiration procedure and reporting. the papanicolaou society of cytopathology task force on standards of practice
.
Mod Pathol
.
1997
;
10
:
739
47
.
10.
Pitman
M
,
Abele
J
,
Ali
S
,
Duick
D
,
Elsheikh
TM
,
Jeffrey
RB
,
Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference
.
Diagn Cytopathol
.
2008 Jun
;
36
(
6
):
407
24
.
11.
Kocjan
G
,
Chandra
A
,
Cross
P
,
Denton
K
,
Giles
T
,
Herbert
A
,
BSCC code of practice: fine needle aspiration cytology
.
Cytopathology
.
2009 Oct
;
20
(
5
):
283
96
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.